Esperion Therapeutics
ESPR
ESPR
101 hedge funds and large institutions have $190M invested in Esperion Therapeutics in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 16 closing their positions.
Holders
101
Holders Change
-1
Holders Change %
-0.98%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
15
Increased
30
Reduced
28
Closed
16
Calls
$2.74M
Puts
$2.77M
Net Calls
-$30K
Net Calls Change
+$199K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$4.42M |
2 |
BB
2
BB Biotech
Schaffhausen,
Switzerland
|
$18.1M |
3 |
3
Northern Trust
Chicago,
Illinois
|
$6.99M |
4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$5.4M |
5 |
IHM
5
Iguana Healthcare Management
New York
|
$1.11M |